Follikuláris limfóma: vizsgálatok itt: Egyesült Királyság
15 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Manchester, Plymouth
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Leeds, Oxford
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- London, Nottingham, Plymouth, Southampton
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- London, Newcastle upon Tyne, Norwich, Nottingham, Plymouth, Southampton
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- London, Manchester, Norwich, Nottingham, Plymouth
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 3. fázisTaking peopleA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Bournemouth, Great Yarmouth, Plymouth, Romford, Salisbury, Sutton, Truro, Uxbridge, Warwick
- Életkor
- 18 év and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00 - 3. fázisTaking peopleA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Bournemouth, Glasgow, Norwich, Plymouth, Romford, Truro
- Életkor
- 18 év and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Edinburgh, Leeds, Newcastle upon Tyne, Newmarket, Norwich, Nottingham, Plymouth
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1. fázisTaking peopleDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
- Where
- Leeds, Plymouth
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116 · EU 2024-516869-36-00 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Glasgow, Leeds, Liverpool, London, Manchester, Oxford, Plymouth, Southampton, Sutton
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Where
- Canterbury, Cringleford, London, Manchester
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00 - 2. fázisTaking peopleRelapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
- Where
- Aberdeen, Belfast, Birmingham, Blackpool, Cambridge, Cardiff, Coventry, Croydon, Glasgow, Leeds, Liverpool, London, Manchester, Newcastle, Norwich, Nottingham, Oxford, Sheffield, Southampton, Stoke-on-Trent, Swansea, Torquay
- Életkor
- 18 év and over
- People
- 284
- Run by
- University of Birmingham
See details and how to joinNCT05848765 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Airdrie, Cheltenham, Manchester, Milton Keynes, Newcastle upon Tyne, Nottingham, Portsmouth, Truro
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - 1/2. fázisTaking peopleA Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
- Where
- Birmingham, Cambridge, Leeds, London, Manchester, Sutton
- Életkor
- 16 év and over
- People
- 84
- Run by
- Cancer Research UK
See details and how to joinNCT06045910 - No phaseNot yet taking people in Egyesült KirályságThe Microbiome in Blood Cancer and HLH
- Where
- Nottingham
- Életkor
- 16 év to 100 év
- People
- 750
- Run by
- University of Nottingham
See details and how to joinNCT06734624